Skip to main content
. 2018 Aug 27;13:2587–2601. doi: 10.2147/COPD.S172240

Figure 2.

Figure 2

The role of ICS in patients with COPD.

Notes: Eosinophil thresholds for beneficial ICS effect are discussed in the text. Data regarding the effect of ICS on comorbidity presence or course are limited.

Abbreviations: ACO, asthma–COPD overlap; ICS, inhaled corticosteroid; LABA, long-acting β2-agonist; LAMA, long-acting muscarinic antagonist; WBCs, white blood cells.